Giants of Cancer Care® Program Inductees

GENITOURINARY CANCER

Maha H. Hussain, MB ChB

University of Michigan Comprehensive Cancer Center

  • Maha H. Hussain, MB ChB, is the Cis Maisel Professor of Oncology and a professor of medicine and urology at the University of Michigan. She serves as the associate director for Clinical Research and co-leader of the Prostate Cancer/GU Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC).
  • Contributed to research that led to the FDA approval of docetaxel for the treatment of men with advanced prostate cancer
  • As lead investigator, evaluated optimal schedules of androgen deprivation therapy for patients with newly diagnosted metastatic prostate cancer through an international collaborative trial
  • Pioneered novel clinical trials in bladder and prostate cancer
  • Guided national research through various leadership positions, including as co-chair of the Prostate Cancer subcommittee of SWOG GU committee, as a member and 2013 chair of the Integration Panel (IP) of US Army Medical Research and Materiel Command Prostate Cancer Research Program, and as a member of the NCI-Cancer Biomarker Study Section and the NCI´s prostate cancer task force
  • Serves as an FDA consultant and has served as a member and chair of the FDA Oncology Drug Advisory Committee
  • Served/serves on the editorial boards of several national and international specialty publications, including the Journal of Clinical Oncology and the American Journal of Translational Research
  • Honored with the University of Michigan Medical School League of Research Excellence award and the 2012 Clinical & Health Services Research award
Back to 2015 Inductees

Home

)

SUPPORTED BY